The peripheral mechanism involves GLP-1 agonist vasoconstriction of smooth muscle, which reduces blood flow and oxygen delivery to the genitals
Studies show that tirzepatide reduces visceral adiposity more effectively than single-pathway medications, addressing not just weight loss but metabolic health
The difference lies in the prescribing indication, not the titration approach
When the bodys antioxidant systems (including glutathione) keep them in check, everything is fine.* However, when free radicals build up and overwhelm the antioxidant systems, we have oxidative stress
The organizations also warn that dependence on GLP-1s alone without an exercise routine or adequate nutrient intake could result in poor long-term outcomes, including loss of muscle mass, diminished functional capacity and widening health inequalities without a well-rounded care plan
We ensure your provider aligns with your plan